Prospective therapeutics for intestinal and hepatic fibrosis

Currently, there are no effective therapies for intestinal and hepatic fibrosis representing a considerable unmet need. Breakthroughs in pathogenesis have accelerated the development of anti‐fibrotic therapeutics in recent years. Particularly, with the development of nanotechnology, the harsh enviro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Yu, Mengli, Zhao, Qingwei, Yu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658571/
https://www.ncbi.nlm.nih.gov/pubmed/38023697
http://dx.doi.org/10.1002/btm2.10579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658571/
https://www.ncbi.nlm.nih.gov/pubmed/38023697
http://dx.doi.org/10.1002/btm2.10579

Ejemplares similares